Specialty Oncology
-
Featured
Revolutionizing Cancer Immunotherapy for Melanoma and Beyond
Researchers at Massachusetts General Hospital won a Breakthrough Award to enhance personalized approaches to immunotherapy for metastatic melanoma.
-
Featured
Lifestyle Medicine Program Offers Care for the Whole Patient
Mass General Cancer Center program focuses on research advances in the role of lifestyle medicine to improve health, well-being, and potentially outcomes for patients with cancer.
-
Helping General Oncologists Make CLL Treatment Decisions
Expert panel develops guidance for chronic lymphocytic leukemia (CLL) treatment decisions to help community oncologists navigate complex selection and sequencing at every stage.
-
From Stroke Detection to Cancer Screening: AI Tools Advancing Imaging Efficiency
Mass General Brigham has developed initiatives for artificial intelligence (AI) governance and inclusion of medical expertise to address an influx of AI technology in medical imaging.
-
Optimizing Treatment Alternatives for Relapsed/Refractory T Cell Lymphomas
Massachusetts General Hospital leads the global PETAL consortium to advance the understanding and treatment of newly diagnosed and relapsed/refractory T cell lymphomas.
-
A Visual Reference for Cancer-related Pain and Associated Treatments
Mass General Brigham physicians have created a graphic and chart to help address cancer-related pain throughout the body.
Mass General Cancer Center Contributors
-
Andrew T. Chan, MD, MPH
Daniel K. Podolsky Professor of Medicine, Harvard Medical School, Director for Cancer Epidemiology, Mass General Cancer Center, Chief, Clinical and Translational Epidemiology Unit, Department of Medicine
Recent Article
Taking Aspirin Associated With Reduction in Colorectal Cancer Among High-Risk Population
-
Areej R. El-Jawahri, MD
Hematologist, Mass General Cancer Center, Assistant in Medicine, Massachusetts General Hospital, Instructor in Medicine, Harvard Medical School
Recent Article
Enasidenib Safe, Well Tolerated As Maintenance After Stem Cell Transplantation for IDH2-Mutated Myeloid Malignancies
-
Chin-Lee Wu, MD, PhD
Director, Genitourinary Pathology Service, Massachusetts General Hospital and Mass General Cancer Center, Professor of Pathology, Harvard Medical School
Recent Article
Multiparametric MRI Is Often False-Negative for Clinically Significant Prostate Cancer
-
Keith T. Flaherty, MD
Director of Clinical Research, Mass General Cancer Center, Professor of Medicine, Harvard Medical School
Recent Article
Program Co-Chair, Keith Flaherty, MD, Recaps Key Highlights From AACR 2024
Mass General Cancer Center
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.
